|
Market Closed -
BME
09:05:01 12/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 57.80 EUR | -0.94% |
|
-1.95% | -8.98% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 20.87x | 4x | 12.67x | 3.85x | 15.12x | 18.15x | 1.65% | 344.36Cr | ||
| 34.45x | 21.73x | 0.64x | 12.59x | 25.62x | 26.88x | 0.57% | 1,08300Cr | ||
| 28.9x | - | -1.56x | - | - | - | 2.07% | 63TCr | ||
| 31.93x | 2383.63x | 0.14x | 7.43x | 15.44x | 16.07x | 2.74% | 44TCr | ||
| 20.56x | 7.38x | 1.73x | 4.87x | 12.07x | 13.39x | 2.71% | 36TCr | ||
| 22.02x | 6.2x | -9.59x | 5.7x | 14.21x | 15.06x | 2.82% | 29TCr | ||
| 20.5x | 4.6x | 1.06x | 4.23x | 12.01x | 12.71x | 2.08% | 25TCr | ||
| 25.99x | 19.59x | 2.17x | 6.83x | 12.15x | 15.67x | 2.43% | 22TCr | ||
| 13.93x | 5.84x | -3.3x | 4.99x | 10.37x | 12.19x | 3.65% | 21TCr | ||
| -42.16x | 8.38x | 0.29x | 6.03x | 34.04x | 58.38x | 2.43% | 17TCr | ||
| 16.79x | 1.73x | 1.01x | 3.2x | 8.3x | 9.3x | 6.47% | 15TCr | ||
| 31.2x | 5.86x | 2.88x | 9.1x | 20.58x | 21.43x | -.--% | 13TCr | ||
| 11.33x | 5.34x | 0.18x | 3.18x | 8.34x | 8.95x | 3.97% | 13TCr | ||
| 11.98x | 1.22x | -7.08x | 2.14x | 6.9x | 7.68x | 5.64% | 10TCr | ||
| 14.06x | 4.56x | -3.15x | 2.8x | 8.28x | 9.23x | 3.67% | 10TCr | ||
| 23.05x | 5.21x | 1.36x | 7.76x | 14.73x | 15.42x | 1.91% | 7.35TCr | ||
| 44.48x | 1.19x | 15.47x | 2.75x | 9.54x | 28.79x | 3.66% | 5.6TCr | ||
| 20.66x | 1.71x | -0.13x | 1.69x | 8x | 13.69x | 0.32% | 5.55TCr | ||
| 39.48x | 5.26x | 2.19x | 8.95x | 29.72x | 31.09x | 0.48% | 5.37TCr | ||
| 19.01x | 1.9x | 4.84x | 3.43x | 12.79x | 14.26x | 2.21% | 4.35TCr | ||
| Average | 20.45x | 131.33x | 1.09x | 5.34x | 14.64x | 18.33x | 2.57% | 22.84TCr | |
| Weighted average by Cap. | 23.96x | 277.28x | -0.32x | 7.38x | 17.17x | 19.69x | 2.22% |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















